Paper Details

  1. Home
  2. Paper Details

Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.

Author: BannaGiuseppe Luigi, ButiSebastiano, CatalanoFabio, CremanteMalvina, DamassiAlessandra, FornariniGiuseppe, GandiniAnnalice, GuadagnoAntonio, Llaja ObispoMiguel Angel, MurianniVeronica, PuglisiSilvia, RebuzziSara Elena, RescignoPasquale

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This abstract describes apalutamide, an oral selective androgen receptor inhibitor approved for the treatment of prostate cancer. The abstract highlights skin reactions as a common side effect and adverse event of special interest.
Paper Details　
Original Abstract of the Article :
Apalutamide is an oral selective androgen receptor inhibitor, approved by the FDA for the treatment of patients with non-metastatic, castration-resistant prostate cancer (M0 CRPC) at high risk of developing metastases and for patients with metastatic castration-sensitive prostate (mHSPC) in associat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/10781552231180598

データ提供：米国国立医学図書館（NLM）

Apalutamide: A Promising Treatment for Prostate Cancer with a Potential Skin Side Effect

Prostate cancer is a prevalent concern, and scientists are constantly searching for effective treatment options. Apalutamide, an oral androgen receptor inhibitor, has shown great promise in treating non-metastatic castrate-resistant prostate cancer (M0 CRPC). This research delves into the potential side effects associated with apalutamide, particularly skin reactions. The study acknowledges that skin reactions are among the most common side effects reported in clinical trials.

Skin Reactions: A Side Effect to Watch Out For

The study identifies lichenoid reaction, a type of skin rash characterized by itchy, scaly patches, as a potential side effect of apalutamide. This finding highlights the importance of monitoring patients treated with apalutamide for skin changes. Early detection of skin reactions can help mitigate potential discomfort and prevent more serious complications.

Health Considerations and Lifestyle Changes

If you are a patient receiving apalutamide for prostate cancer, it is crucial to be aware of potential skin reactions and report any changes to your doctor. While apalutamide is a promising treatment, it's important to be vigilant about potential side effects and communicate openly with your healthcare providers.

Dr. Camel's Conclusion

Just like a camel navigating a desert needs to be aware of potential hazards, patients undergoing apalutamide treatment should be mindful of the potential for skin reactions. This research underscores the importance of patient education and close monitoring to ensure safe and effective treatment.

Date :
  1. Date Completed 2023-10-30
  2. Date Revised 2023-10-30
Further Info :

Pubmed ID

37282554

DOI: Digital Object Identifier

10.1177/10781552231180598

Related Literature

Article Analysis
・Side Effects of apalutamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.